PHARMACEUTICAL COMPOSITION CONTAINING TRANSFER FACTOR FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND REGRESSIVE BEHAVIOURAL DISORDER

摘要

The present invention concerns a pharmaceutical composition for the treatmentof an MMR virus mediated disease comprising a soluble dialysed leucocyteextract comprising a transfer factor (TF) formed by the dialysis of virus-specific lymphocytes to a molecular weight filter cut-off of 12,500 disposedin a pharmaceutically acceptable carrier or diluent therefor.